Exome sequencing has found a similar pattern of clonal tumor mutational burden, intratumor heterogenicity, and clonal neoantigen between an autologous tumor and a Vigil product. This finding is related to research on tumor genetics and evolution, with studies exploring topics such as clonal analysis and whole genome sequencing in various types of cancer. The specific implications of this discovery are not clear from the available information.